GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Regnum RGMP · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Price performance

Chart by TradingView, with its own licensed prices

Regnum — daily RGMP Delayed
Market value
$2,295
Last close × shares
Volume
600
Shares, 30 Oct 2026

About Regnum

Its shares trade under the ticker RGMP. It has been listed since 15 March 2019. In the fiscal year to 31 December 2021, it reported revenue of $9,000 and a net loss of $270,000. At that date it held total assets of $1.5m and shareholders' equity of −$379,823.

Regnum Corp. engages in the business of developing and commercializing therapeutics that treat rare and infectious diseases. The company is headquartered in New York City, New York. The company went IPO on 2019-03-15. The firm's primary asset is the commercial rights to leronlimab (PRO 140) in all human immunodeficiency virus (HIV) indications within the United States. Leronlimab is a monoclonal antibody. The target of leronlimab is the immunologic receptor CCR5. Leronlimab prevents certain strains of HIV from using the CCR5 receptor as an entry gateway for healthy cells. The leronlimab antibody belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells. Leronlimab blocks HIV from entering a cell by binding to a molecule called CCR5 referred to as R5 strains, attach as part of HIVs entry into a cell.

Figures and description from our data supplier, not checked against the company's own report.

More about Regnum →

Latest on Regnum

Our reporting

We have not reported on Regnum yet.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Regnum's ticker?

Regnum trades as RGMP on its US listing, under ISIN US75915R1068.

What was Regnum's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.